Hulic (3003.T): H1 results - underlying profit growth in double digits, but in line

Research evidence excerpt

Hulic (3003.T): H1 results - underlying profit growth in double digits, but in line

sign “Rating Suspended” status for regulatory and/or internal policy reasons. Citi Research may also

suspend its rating and target price and assign "Under Review" status for other exceptional circumstances (e.g. lack of

information critical to the analyst's thesis, trading suspension) affecting the company and/or trading in the company's

securities. In both such situations, the rating and target price will show as “—“ and “-“ respectively in the rating history price

chart. Prior to 11 April 2022 Citi Research assigned “Under Review” status to both situations and prior to 11 Nov 2020 only in

exceptional circumstances. As soon as practically possible, the analyst will publish a note re-establishing a rating and

investment thesis. Investment ratings are determined by the ranges described above at the time of initiation of coverage, a

change in investment and/or risk rating, or a change in target price (subject to limited management discretion). At times, the

expected total returns may fall outside of these ranges because of market price movements and/or other short-term volatility

or trading patterns. Such interim deviations will be permitted but will become subject to review by Research Management.

Your decision to buy or sell a security should be based upon your personal investment objectives and should be made only

after evaluating the stock's expected performance and risk.

Catalyst Watch/Short Term Views (“STV”) Ratings Disclosure:

Catalyst Watch and STV Upside/Downside calls: Citi Research may also include a Catalyst Watch or STV Upside or Downside

call to indicate the analyst expects the share price to rise (fall) in absolute terms over a specified period of 30 or 90 days in